99 related articles for article (PubMed ID: 24798669)
1. Use of the Papanicolaou test in women under 25 years of age in Southern Alberta.
Snodgrass R; Naugler C
J Obstet Gynaecol Can; 2014 Apr; 36(4):320-3. PubMed ID: 24798669
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
Qin J; Saraiya M; Martinez G; Sawaya GF
JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
[TBL] [Abstract][Full Text] [Related]
3. Screening with Papanicolaou tests in Alberta: Are we Choosing Wisely?
Symonds CJ; Chen W; Rose MS; Cooke LJ
Can Fam Physician; 2018 Jan; 64(1):47-53. PubMed ID: 29358254
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening among women without a cervix.
Sirovich BE; Welch HG
JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
[TBL] [Abstract][Full Text] [Related]
6. A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.
Collins T; Stradtman LR; Vanderpool RC; Neace DR; Cooper KD
Am J Prev Med; 2015 Aug; 49(2):324-30. PubMed ID: 26190807
[TBL] [Abstract][Full Text] [Related]
7. Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy.
Teoh D; Isaksson Vogel R; Hultman G; Monu M; Downs L; Geller MA; Le C; Melton-Meaux G; Kulasingam S
Obstet Gynecol; 2017 Mar; 129(3):448-456. PubMed ID: 28178049
[TBL] [Abstract][Full Text] [Related]
8. Cervical Screening Practices and Outcomes for Young Women in Response to Changed Guidelines in Calgary, Canada, 2007-2016.
Sayed SA; Naugler C; Chen G; Dickinson JA
J Low Genit Tract Dis; 2021 Jan; 25(1):1-8. PubMed ID: 33149010
[TBL] [Abstract][Full Text] [Related]
9. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
Al Rifai R; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
[TBL] [Abstract][Full Text] [Related]
10. U.S. Preventive Services Task Force recommendations and cancer screening among female Medicare beneficiaries.
Salloum RG; Kohler RE; Jensen GA; Sheridan SL; Carpenter WR; Biddle AK
J Womens Health (Larchmt); 2014 Mar; 23(3):211-7. PubMed ID: 24195774
[TBL] [Abstract][Full Text] [Related]
11. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
White MC; Shoemaker ML; Benard VB
Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
[TBL] [Abstract][Full Text] [Related]
13. Sociodemographic factors of Pap smear screening in Taiwan.
Wang PD; Lin RS
Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
[TBL] [Abstract][Full Text] [Related]
14. Knowledge, attitude and practice of the pap smear as a screening procedure among nurses in a tertiary hospital in north eastern India.
Thippeveeranna C; Mohan SS; Singh LR; Singh NN
Asian Pac J Cancer Prev; 2013; 14(2):849-52. PubMed ID: 23621250
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines.
Solomon D; Breen N; McNeel T
CA Cancer J Clin; 2007; 57(2):105-11. PubMed ID: 17392387
[TBL] [Abstract][Full Text] [Related]
16. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
17. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
18. Roles of Health Care Providers and Patients in Initiation of Unnecessary Papanicolaou Testing After Total Hysterectomy.
Guo F; Kuo YF
Am J Public Health; 2016 Nov; 106(11):2005-2011. PubMed ID: 27631753
[TBL] [Abstract][Full Text] [Related]
19. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
[TBL] [Abstract][Full Text] [Related]
20. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]